EcoDrugPlus

40s Ribosomal Protein S24

Ensembl ID : ENSSTUG00000008396
Gene Symbol: LOC115153341
3 Cross references
482 Possible Orthologues:

40s Ribosomal Protein S25-Like

Ensembl ID : ENSSTUG00000045337
Gene Symbol: LOC115163514
3 Cross references
444 Possible Orthologues:

40s Ribosomal Protein S25-Like

Ensembl ID : ENSSTUG00000030267
Gene Symbol: LOC115206426
3 Cross references
444 Possible Orthologues:

40s Ribosomal Protein S28

Ensembl ID : ENSSTUG00000048340
Gene Symbol: LOC115169966
3 Cross references
274 Possible Orthologues:

40s Ribosomal Protein S3a

Ensembl ID : ENSSTUG00000000966
Gene Symbol: LOC115202224
3 Cross references
358 Possible Orthologues:

40s Ribosomal Protein S3a

Ensembl ID : ENSSTUG00000007367
Gene Symbol: LOC115191805
3 Cross references
358 Possible Orthologues:

40s Ribosomal Protein S4

Ensembl ID : ENSSTUG00000032067
Gene Symbol: LOC115198593
3 Cross references
488 Possible Orthologues:

40s Ribosomal Protein S4-Like

Ensembl ID : ENSSTUG00000043091
Gene Symbol: LOC115190148
3 Cross references
488 Possible Orthologues:

40s Ribosomal Protein S5

Ensembl ID : ENSSTUG00000048025
Gene Symbol: LOC115173319
3 Cross references
258 Possible Orthologues:

40s Ribosomal Protein S5

Ensembl ID : ENSSTUG00000031195
Gene Symbol: LOC115176027
3 Cross references
258 Possible Orthologues:

40s Ribosomal Protein S7

Ensembl ID : ENSSTUG00000000181
Gene Symbol: LOC115165272
3 Cross references
352 Possible Orthologues:

40s Ribosomal Protein S9

Ensembl ID : ENSSTUG00000015141
Gene Symbol: LOC115177525
3 Cross references
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).